We are live on ! Find out more
BIO icon

Bio-Rad Laboratories Class A
BIO

490 hedge funds and large institutions have $11.5B invested in Bio-Rad Laboratories Class A in 2020 Q4 according to their latest regulatory filings, with 76 funds opening new positions, 177 increasing their positions, 176 reducing their positions, and 57 closing their positions.

New
Increased
Maintained
Reduced
Closed

40% more funds holding in top 10

Funds holding in top 10: 5 → 7 (+2)

33% more first-time investments, than exits

New positions opened: 76 | Existing positions closed: 57

16% more capital invested

Capital invested by funds: $9.85B → $11.5B (+$1.61B)

3% more funds holding

Funds holding: 478 → 490 (+12)

1.14% more ownership

Funds ownership: 78.38% → 79.52% (+1.1%)

1% more repeat investments, than reductions

Existing positions increased: 177 | Existing positions reduced: 176

8% less call options, than puts

Call options by funds: $14.7M | Put options by funds: $16M

Holders
490
Holders Change
+12
Holders Change %
+2.51%
% of All Funds
8.67%
Holding in Top 10
7
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+40%
% of All Funds
0.12%
New
76
Increased
177
Reduced
176
Closed
57
Calls
$14.7M
Puts
$16M
Net Calls
-$1.25M
Net Calls Change
+$4.17M

Top Buyers

1
Fidelity Investments
Fidelity Investments
Massachusetts
+$164M
2
BlackRock
BlackRock
New York
+$154M
3
HM
HealthCor Management
New York
+$79.8M
4
California Public Employees Retirement System
California Public Employees Retirement System
California
+$72.4M
5
UBS AM
UBS AM
Illinois
+$66.9M

Top Sellers

1
GQG Partners
GQG Partners
Florida
-$183M
2
American Century Companies
American Century Companies
Missouri
-$102M
3
ACM
Atlanta Capital Management
Georgia
-$89.1M
4
AQR Capital Management
AQR Capital Management
Connecticut
-$48.1M
5
Wells Fargo
Wells Fargo
California
-$42.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
CB
326
Commerce Bank
Missouri
$454K -$47.3K -83 -10%
AII
327
AGF Investments Inc
Ontario, Canada
$452K +$3.42K +6 +0.8%
BIAS
328
Beacon Investment Advisory Services
New Jersey
$439K – – –
CCM
329
Cohen Capital Management
California
$437K – – –
Cambridge Investment Research Advisors
330
Cambridge Investment Research Advisors
Iowa
$437K +$155K +273 +57%
SF
331
Synovus Financial
Georgia
$433K -$515K -905 -55%
ZIM
332
Zacks Investment Management
Illinois
$432K – – –
UAS
333
United Asset Strategies
New York
$426K – – –
CFG
334
Cooper Financial Group
California
$417K -$10.8K -19 -3%
GTCM
335
Gyon Technologies Capital Management
New Jersey
$417K +$60.4K +106 +17%
LP
336
LMR Partners
United Kingdom
$415K +$405K +712 New
JCM
337
JS Capital Management
New York
$408K +$399K +700 New
Squarepoint
338
Squarepoint
New York
$399K -$512K -899 -57%
DY
339
Dowling & Yahnke
California
$397K -$42.1K -74 -10%
KAS
340
Kestra Advisory Services
Texas
$394K +$388K +682 +17,050%
MG
341
Meritage Group
California
$392K -$50.7K -89 -12%
Vontobel Holding
342
Vontobel Holding
Switzerland
$362K +$328K +576 New
PA
343
Parallel Advisors
California
$361K +$30.8K +54 +10%
Creative Planning
344
Creative Planning
Kansas
$352K +$33K +58 +11%
Mercer Global Advisors
345
Mercer Global Advisors
Colorado
$352K +$344K +604 New
ECM
346
ExodusPoint Capital Management
New York
$350K -$1.69M -2,959 -83%
KRSITF
347
Kentucky Retirement Systems Insurance Trust Fund
Kentucky
$347K +$19.4K +34 +6%
BCM
348
BTR Capital Management
California
$344K – – –
BMSSC
349
B. Metzler seel. Sohn & Co
Germany
$339K +$336K +590 New
VI
350
Versor Investments
New York
$332K -$2.17M -3,807 -87%
12 13
14
15 16

BIO Hedge Fund Activity: Q4 2020 in Review

490 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Bio-Rad Laboratories Class A (BIO) for Q4 2020, worth a combined $11.5B — up 16% from $9.85B a quarter earlier.

Buyers outnumbered sellers: 76 funds opened new BIO positions and 57 closed out — a net gain of 19 holders — while 177 added to existing stakes and 176 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $164M. The largest seller was GQG Partners, exiting entirely with an estimated $183M sold.

  • 490 institutional investors held Bio-Rad Laboratories Class A (BIO) as of Q4 2020, up from 478 in Q3 2020.
  • Funds reported $11.5B of Bio-Rad Laboratories Class A stock for Q4 2020, up 16% quarter-over-quarter.
  • 76 funds opened new Bio-Rad Laboratories Class A positions in Q4 2020 and 57 closed out, a net change of +19 holders.
  • The largest Bio-Rad Laboratories Class A buyer in Q4 2020 was Fidelity Investments, an estimated $164M added.
  • The largest Bio-Rad Laboratories Class A seller in Q4 2020 was GQG Partners, an estimated $183M sold.

Based on aggregated 13F filings for Q4 2020.